SCHEMBL23974015

SCHEMBL23974015

CC(C)(C)CC1NC(=O)CNC1=O

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13644716 1.00 HRH3 (0.35) HRH3
SCHEMBL14250375 0.81 HRH3 (0.35) HRH3
SCHEMBL417814 0.78 HRH3 (0.37) HRH3
SCHEMBL6948618 0.78 HRH3 (0.37) HRH3
SCHEMBL13754182 0.77 HRH3 (0.33) HRH3
SCHEMBL23974093 0.76 CCR2 (0.39) HRH3
SCHEMBL4402037 0.75 HRH3 (0.38) HRH3
SCHEMBL4410585 0.75 HRH3 (0.38) HRH3
SCHEMBL12334338 0.75 HRH3 (0.38) HRH3
SCHEMBL31509521 0.74 GHSR (0.41) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210337850-A1 SAVOURY AND MOUTHFULNESS TASTE ENHANCERS LUCTA, S.A. (ES) 2021-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210337850-A1 SAVOURY AND MOUTHFULNESS TASTE ENHANCERS KCNJ6, TAS1R1, TAS2R5 HRH3 1842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.